Trials / Conditions / Nipah Virus Infection

Nipah Virus Infection

5 registered clinical trials studyying Nipah Virus Infection — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910	Institut Pasteur du Cambodge	—
Completed	Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV NCT06221813	Public Health Vaccines LLC	Phase 1
Completed	Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Viru NCT05398796	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Completed	A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adu NCT05178901	Public Health Vaccines LLC	Phase 1
Completed	Safety and Immunogenicity of a Nipah Virus Vaccine NCT04199169	Auro Vaccines LLC	Phase 1